Name | 4,6-dibenzamidobenzene-1,3-dicarboxylic acid |
---|---|
Synonyms |
NS3763
5-Carboxy-2,4-dibenzamidobenzoic acid |
Description | NS3763 is a selective and noncompetitive GLUK5 receptor antagonist with an IC50 of 1.6 µM. NS3763 does not show significant antagonistic properties on GLUK6, AMPA or NMDA receptors[1]. |
---|---|
Related Catalog | |
Target |
IC50: 1.6 µM (GLUK5 receptor)[1] |
In Vitro | In human embryonic kidney HEK293 cells expressing homomeric GLUK5 or GLUK6 receptors, NS3763 displays selectivity for inhibition of domoate-induced increase in intracellular calcium mediated through the GLUK5 subtype (IC50 = 1.6 µM) of kainate receptors compared with the GLUK6 subtype (IC50 > 30 µM)[1]. NS3763 selectively inhibits l-glutamate- and domoate-evoked currents through GLUK5 receptors in HEK293 cells[1]. |
References |
Density | 1.485g/cm3 |
---|---|
Boiling Point | 490.7ºC at 760 mmHg |
Molecular Formula | C22H16N2O6 |
Molecular Weight | 404.37200 |
Flash Point | 250.6ºC |
Exact Mass | 404.10100 |
PSA | 132.80000 |
LogP | 3.73360 |
Index of Refraction | 1.735 |
Symbol |
GHS07, GHS09 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335-H410 |
Precautionary Statements | P261-P273-P305 + P351 + P338-P501 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xi,N |
Risk Phrases | 36/37/38-50/53 |
Safety Phrases | 26-36-60-61 |
RIDADR | UN 3077 9/PG 3 |